Hledat
Zobrazují se záznamy 1-2 z 2
Development of antimicrobial agents with activity against drug-resistant bacteria
(2022)
Tuberculosis (TB) is a widespread infectious disease predominantly caused by Mycobacterium tuberculosis (M. tuberculosis). The discovery and widespread use of antimicrobials effective against TB starting in the middle of ...
Novel 4-aminosalicylic acid analogues active against multidrug-resistant tuberculosis
(2022)
Spread of drug-resistant Mycobacterium tuberculosis (Mtb.), together with latent tuberculosis (TB), COVID-19 co-infection and increasing prevalence of non-tuberculous mycobacteria (NTM), is a serious threat for public ...